Allarity Therapeutics, Inc.
ALLR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,844 | $658,261 | $2,715 | $61,002 |
| - Cash | $19,533 | $166 | $2,029 | $19,555 |
| + Debt | $1,350 | $1,300 | $3,735 | $1,086 |
| Enterprise Value | -$16,339 | $659,395 | $4,421 | $42,533 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$24,234 | -$11,283 | -$17,296 | -$25,769 |
| % Margin | – | – | – | – |
| Net Income | -$24,515 | -$11,901 | -$16,058 | -$26,648 |
| % Margin | – | – | – | – |
| EPS Diluted | -15.791 | -6,153.264 | -1,856,055 | -3,520,104 |
| % Growth | 99.7% | 99.7% | 47.3% | – |
| Operating Cash Flow | -$17,352 | -$12,745 | -$16,817 | -$15,050 |
| Capital Expenditures | -$298 | $0 | -$18 | $0 |
| Free Cash Flow | -$17,650 | -$12,745 | -$16,835 | -$15,050 |